This could be a good time to focus on the neurological device sector: The market for these tools is on the upswing and projected to hit $5 billion by 2020, thanks to an increase in neurological procedures (and better available technology), a report form Canadian firm iData Research says.

The neuromodulation sector is expected to perform well, the report says. This includes spinal cord stimulators, vagus nerve stimulators, deep brain stimulators, gastric electric stimulators and sacral nerve stimulators. And research is finding that deep brain stimulators are showing more and more promise in treating a number of movement disorders. Modern Healthcare says:

Neurological devices have traditionally made up smaller revenue segments for large devicemakers. However, as more commonly used implantable products such as pacemakers and hip implants face pricing pressure from hospitals, devicemakers are looking for new ways to buy and develop innovative technologies that can help maintain their margins.

Medtronic’s leading the market in this sector, the report says, with notable competitors like Boston Scientific, St. Jude Medical and Cyberonics.

Notably, the NIH is getting in on this idea – it just launched a challenge to crowdsource ways to commercialize existing neurological devices.